Article
Antitumor immunity in dMMR colorectal cancers requires interferon-induced CCL5 and CXCL10
medRxiv · 2020 · Courtney Mowat
Key facts
| Title | Antitumor immunity in dMMR colorectal cancers requires interferon-induced CCL5 and CXCL10 |
|---|---|
| First author | Courtney Mowat |
| Journal | medRxiv |
| Published | Sep 16, 2020 |
| DOI | 10.1101/2020.09.15.291765 |
| Devices mentioned | BK110039, K893036 |
| Product codes mentioned | KIP, KIT, MVU, NDS, NJT, PFT, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1